HybridSPE: A novel technique to reduce phospholipid-based matrix effect in LC-ESI-MS Bioanalysis

Journal of Pharmacy and Bioallied Sciences

Volumn 4, Issue 4, 2012, Pages 267-275

  Ahmad, Shafeeque ^a   Kalra, Harsh ^a   Gupta, Amit ^a   Raut, Bharat ^b   Hussain, Arshad ^c   Rahman, Md Akhlaquer ^c  

^a SVKM s Narsee Monjee Institute of Management Studies   (India)

^b AshcoNeulab Ltd   (India)

^c INTEGRAL UNIVERSITY   (India)

Author keywords

Bioanalytical; electro spray ionization; HybridSPE; matrix effects; phospholipids

Indexed keywords

BIOMATERIAL; PHOSPHOLIPID;

ANALYSIS; ASSAY; BIOANALYSIS; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; LIQUID CHROMATOGRAPHY; MATRIX EFFECT; PRECIPITATION; PRIORITY JOURNAL; QUADRUPOLE MASS SPECTROMETRY; REVIEW; SAMPLE; SIGNAL PROCESSING; SOLID PHASE EXTRACTION;

EID: 84870173641     PISSN: None     EISSN: 09757406     Source Type: Journal    
DOI: 10.4103/0975-7406.103234     Document Type: Review

References (34)

1. Shou WZ, Naidong W. Post-column infusion study of the 'dosing vehicle effect' in the liquid chromatography/tandem mass spectrometric analysis of discovery pharmacokinetic samples. Rapid Commun Mass Spectrom 2003;17:589-97.
2. Ismaiel OA, Halquist MS, Elmamly MY, Shalaby A, Karnes HT. Monitoring phospholipids for assessment of matrix effects in a liquid chromatography-tandem mass spectrometry method for hydrocodone and pseudoephedrine in human plasma. Analyt Technol Biomed Life Sci 2007;859:84-93.
3. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: Influence of ionization type, sample preparation, and biofluid. J Am Soc Mass Spectrom 2003;14:1290-4.
4. Taylor PJ. Matrix effects: The achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 2005;38:328-34.
5. van De Steene JC, Mortier KA, Lambert WE. Tackling matrix effects during development of a liquid chromatographic-electrospray ionization tandem mass spectrometric analysis of nine basic pharmaceuticals in aqueous environmental samples. J Chromatogr A 2006;1123:71-81.
6. Jemal M, Xia YQ. LC-MS Development strategies for quantitative bioanalysis. Curr Drug Metab 2006;7:491-502.
7. Souverain S, Rudaz S, Veuthey J. Matrix effect in LC-ESI-MS and LC-APCI-MS with off-line and on-line extraction procedures. J Chromatogr A 2004;1058:61-6.
8. Matuszewski BK, Constanzer ML, Chavez-Eng CM. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLCMS/MS. Anal Chem 2003;75:3019-30.
9. Little JL, Wempe MF, Buchanan CM. Liquid chromatography-mass spectrometry/mass spectrometry method development for drug metabolism studies: Examining lipid matrix ionization effects in plasma. J Chromatogr B 2006;833:219-30.
10. Myher JJ, Kuksis A, Pind S. Molecular species of glycerophospholipids and sphingomyelins of human plasma: Comparison to red blood cells. Lipids 1989;24:408-18.
11. Mei H, Korfmacher M. Using Mass Spectrometry for Drug Metabolism StudiesBoca Raton, FL: CRC Press; 2005. p. 103-50.
12. Shen JX, Motyka RJ, Roach JP, Hayes RN. Minimization of ion suppression in LC-MS/MS analysis through the application of strong cation exchange solid-phase extraction (SCX-SPE). J Pharm Biomed Anal 2005;37:359-67.
13. King R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T. Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom 2000;11:942-50.
14. Chambers E, Wagrowski-Diehl DM, Lu Z, Mazzeo Jr. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J Chromatogr B 2007;852:22-34.
15. Marchese A, McHugh C, Kehler J, Bi H. Determination of pranlukast and its metabolites in human plasma by LC/MS/MS with PROSPEKT TM on-line solid-phase extraction. J Mass Spectrom 1998;33:1071-9.
16. Bonfiglio R, King RC, Olah T, Merkle K. The effects of sample preparation methods on the variability of the electrospray ionization response for model drug compounds. Rapid Commun Mass Spectrom 1999;13:1175-85.
17. Liu DQ, Pereira T. Interference of a carbamoylglucuronides metabolite in quantitative liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2002;16:142-6.
18. Pucci V, Palma SD, Alferi A, Bonelli F, Monteagudo E. A novel strategy for reducing phospholipids-based matrix effect in LC-ESI-MS bioanalysis by means of HybridSPE. J Pharm Biomed Anal 2009;50:867-71.
19. Sigmaaldrich.com. USA: Sigma-Aldrich. Available from: http://www.sigmaaldrich.com/Graphics/Supelco/objects/4600/4538.pdf[Last accessed on 2010 Jan 12].
20. Guo JF, Zhao YM, Zhao L, Zhang WQ, Zhang AJ, Xu B. Simultaneous quantification of CTN986 and its deglycosylation products in rat serum using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2006;20:1701-8.
21. Xing J, Chen X, Zhong D. Stability of baicalin in biological fluids in vitro. J Pharm Biomed Anal 2005;39:593-600.
22. Ji HY, Lee HW, Kim HK, Kim HH, Chang SG, Sohn DH, et al. Simultaneous determination of ginsenoside Rb(1) and Rg(1) in human plasma by liquid chromatography-mass spectrometry. J Pharm Biomed Anal 2004;35:207-12.
23. Soepenberg O, de Bruijn P, Verweij J, Atsumi R, Sparreboom A. Liquid chromatographic assays for DE-310, a novel camptothecinanalog, and two major enzymatic products in human matrices. J Chromatogr B 2004;799:15-22.
24. Zhao HQ, Qu Y, Wang XY, Lu XY, Zhang XH, Hattori M. Determination of trigonelline by HPLC and study on its pharmacokinetics. Yao XueXueBao 2003;38:279-82.
25. Kaneko R, Hattori S, Furuta S, Hamajima M, Hirata Y, Watanabe K, et al. Sensitive analysis of aconitine, hypaconitine, mesaconitine and jesaconitine in human body fluids and Aconitum-tubers by LC/ESI-TOF-MS.J Mass Spectrom 2006;41:810-4.
26. Guo W, Ahmad A, Khan S, Dahhani F, Wang YF, Ahmad I. Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy- camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38). J Chromatogr B 2003;79:85-92.
27. Zhai S, Sausville E, Figg WD. A high-performance liquid chromatography method using ultraviolet detection for the quantitation of flavopiridol from human plasma. Biomed Chromatogr 2002;16:379-82.
28. Wang XL, Xing DM, Wang W, Su H, Tao JL, Du LJ. Pharmacokinetics of Berberine in Rat Thalamus after Intravenous Administration of Coptidis Rhizoma Extract. Am J Chin Med 2005;33:935-43.
29. Cheng X, Shin YG, Levine BS, Smith AC, Tomaszewski JE, van Breemen RB. Quantitative analysis of betulinic acid in mouse, rat and dog plasma using electrospray liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 2003;17:2089-92.
30. Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS. J Pharm Biomed Anal 2007;44:342-55.
31. Tan ZR, Ouyang DS, Zhou G, Wang LS, Li Z, Wang D, et al. Sensitive bioassay for the simultaneous determination of pseudoephedrine and cetirizine in human plasma by liquid-chromatography-ion trap spectrometry. J Pharm Biomed Anal 2006;42:207-12.
32. Murphy CM, Huestis MA. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-D-glucuronide, morphine-6-D-glucuronide, and codeine-6-D-glucuronide in human urine. J Mass Spectrom 2005;40:1412-6.
33. Samanidou VF, Evaggelopoulou EN, Papadoyannis IN. Simultaneous determination of quinine and chloroquine anti-malarial agents in pharmaceuticals and biological fluids by HPLC and fluorescence detection. J Pharm Biomed Anal 2005;38:21-8.
34. Xing J, Xie C, Lou H. Recent application of liquid chromatography-mass spectrometry in natural product. J Pharm Biomed Anal 2007;44:368-78.